Postherpetic Neuralgia News
Most Popular Postherpetic Neuralgia Story
NeurogesX reports positive Phase III data
NeurogesX is touting positive data from the second late-stage study of NGX-4010, a dermal patch therapy for patients with postherpetic neuralgia. The study hit its primary endpoint with a 32 percent... Read more...
Latest Headlines
- September 17, 2007
- September 4, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
